Jump to main content
Jump to site search

Issue 1, 2016
Previous Article Next Article

Serum protein biomarkers relevant to hepatocellular carcinoma and their detection

Author affiliations

Abstract

Hepatocellular carcinoma (HCC) is one of the most recurrent and lethal cancers worldwide. The low survival rate of this particular strain of carcinoma is largely due to the late stages at which it is diagnosed. Tumorigenesis of hepatocellular carcinoma is most frequently detected through ultrasonography, magnetic resonance imaging and computerized tomography scans, however, these methods are poor for detection of early tumor development. This review presents alternative hepatocellular carcinoma detection techniques through the use of protein and enzyme/isozyme biomarkers. The detection methods used to determine the serum levels of α-fetoprotein (AFP), glypican-3 (GPC3), Golgi protein 73 (GP73), α-L-fucosidase (AFU), des-γ-carboxyprothrombin (DCP), γ-glutamyl transferase (GGT) and squamous cell carcinoma antigen (SCCA) are presented and each marker's respective validity in the diagnosis of hepatocellular carcinoma is evaluated.

Graphical abstract: Serum protein biomarkers relevant to hepatocellular carcinoma and their detection

Back to tab navigation

Publication details

The article was received on 11 Sep 2015, accepted on 02 Nov 2015 and first published on 11 Nov 2015


Article type: Critical Review
DOI: 10.1039/C5AN01884F
Author version available: Download Author version (PDF)
Citation: Analyst, 2016,141, 36-44
  •   Request permissions

    Serum protein biomarkers relevant to hepatocellular carcinoma and their detection

    E. Waidely, A. O. Al-Yuobi, A. S. Bashammakh, M. S. El-Shahawi and R. M. Leblanc, Analyst, 2016, 141, 36
    DOI: 10.1039/C5AN01884F

Search articles by author

Spotlight

Advertisements